SCHEMBL2092307

SCHEMBL2092307

[CH2]c1cccc(Oc2ccc(Cl)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.47
MAOA P21397 2/20 0.47
ALDH1A1 P00352 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
MITF O75030 1/20 0.45
GAA P10253 1/20 0.45
GFER P55789 1/20 0.45
NLRP1 Q9C000 1/20 0.45
NOD2 Q9HC29 1/20 0.45
HPGD P15428 2/20 0.44
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
LMNA P02545 1/20 0.42
ADAMTS5 Q9UNA0 1/20 0.40
PGR P06401 1/20 0.39
AR P10275 1/20 0.39
F2 P00734 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5543835 0.86 AR (0.44) SMN1; SMN2MAPTLMNAARCYP1A2
SCHEMBL16890736 0.85 ALDH1A1 (0.60) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL10547368 0.84 TERT (0.46) MAOBALDH1A1SMN1; SMN2MEN1MAPT
SCHEMBL95809 0.83 LTA4H (0.57) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL3294395 0.82 KMO (0.56) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL9343331 0.81 LTA4H (0.55) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL3716891 0.81 MAOA (0.52) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL29349910 0.81 MAOA (0.52) MAOBMAOAALDH1A1SMN1; SMN2MEN1
SCHEMBL5545085 0.80 AR (0.46) ALDH1A1SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL9339340 0.80 MAPT (0.47) MAOBMAOAALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392643-A2 TRISUBSTITUTED-N- (1S)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL] BENZAMIDES WHICH INHIBIT P2X3 AND P2X2/3 CONTAINING RECEPTORS Abbott Laboratories (US) 2004-03-03 EP claimed
US-20040014764-A1 N-myristoyltransferase inhibitor compositions and methods of use SMITH CHARLES D (US) 2004-01-22 US claimed
WO-2002094767-A2 TRISUBSTITUTED-N-[(1S)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL] BENZAMIDES WHICH INHIBIT P2X3 AND P2X2/3 CONTAINING RECEPTORS ABBOTT LABORATORIES (US) 2002-11-28 WO claimed
US-5916920-A CONTROLLING NEUROTRANSMITTER RECPETORS; NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS ELI LILLY AND COMPANY (US) 1999-06-29 US claimed
WO-1997017950-A1 SHOULDER PROSTHESIS ELI LILLY AND COMPANY (US) 1997-05-22 WO claimed
EP-0774455-A1 Excitatory amino acid receptor antagonists ELI LILLY AND COMPANY (US) 1997-05-21 EP claimed
US-5091416-A INSECTICIDAL COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-02-25 US claimed
US-5045566-A Phenyl or naphthyl substituted ICI AMERICAS INC. (US) 1991-09-03 US claimed
US-4994473-A For plants ICI AMERICAS INC. (US) 1991-02-19 US claimed
EP-0361694-A2 Insecticidal compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-04-04 EP claimed
EP-0361695-A2 Insecticidal compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-04-04 EP claimed
EP-0295839-A2 Pyrimidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-12-21 EP claimed
EP-0091208-B1 METHOD FOR COMBATING INSECT PESTS, AND NOVEL CYCLOPROPANE CARBOXYLATES USEFUL AS ACTIVE INGREDIENTS THEREIN IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-06-18 EP claimed
EP-2048953-B1 INSECTICIDAL COMPOSITION MCLAUGHLIN GORMLEY KING CO (US) 2020-11-18 EP disclosed
EP-1389216-B1 AVERMECTINS SUBSTITUTED IN THE 4\"-POSITION HAVING PESTICIDAL PROPERTIES MERIAL INC (US) 2017-02-22 EP disclosed
CN-101534647-B insecticide composition LIVIE BIOPESTICIDES LTD 2012-11-28 CN disclosed
US-4411912-A Insecticidal isovaleric acid esters ZOECON CORPORATION (US) 1983-10-25 US disclosed
EP-0091208-A1 Method for combating insect pests, and novel cyclopropane carboxylates useful as active ingredients therein IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-10-12 EP disclosed
US-4397864-A LOW TOXICITY MITSUITOATSU CHEMICALS INC. (JP) 1983-08-09 US disclosed
US-4243819-A Substituted amino acids ZOECON CORPORATION (US) 1981-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014764-A1 N-myristoyltransferase inhibitor compositions and methods of use NMT2, NMT1, MBOAT1 MAOB 1912/4885MAOA 2515/4885ALDH1A1 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.